NIAID Banner Logo Image

HBV Citations List: March 2023

Literature Citations

1. Potential Antiviral Activities of Chrysin against Hepatitis B Virus. Bhat, S.A., S.K. Hasan, Z.A. Parray, Z.I. Siddiqui, S. Ansari, A. Anwer, S. Khan, F. Amir, M. Mehmankhah, A. Islam, Z. Minuchehr, and S.N. Kazim. Gut Pathogens, 2023. 15(1): 11. PMID[36895013].
[PubMed]. HBV_03_2023.

2. Design and Synthesis of (3-Phenylisoxazol-5-yl)methanimine Derivatives as Hepatitis B Virus Inhibitors. Liang, Z., Y. Tan, Y. Huang, T. Liang, W. Wei, M. Wang, and K. Shi. Chemistry & Biodiversity, 2023. 20(3): e202201247. PMID[36811262].
[PubMed]. HBV_03_2023.

3. Sphondin Efficiently Blocks HBsAg Production and cccDNA Transcription through Promoting HBx Degradation. Ren, F., J. Hu, Y. Dang, H. Deng, J. Ren, S. Cheng, M. Tan, H. Zhang, X. He, H. Yu, J. Zhang, Z. Zhang, W. Chen, J. Hu, X. Cai, Y. Hu, A. Huang, and J. Chen. Journal of Medical Virology, 2023. 95(3): e28578. PMID[36846971].
[PubMed]. HBV_03_2023.

4. Synthesis and Evaluation of N-Sulfonylpiperidine-3-carboxamide Derivatives as Capsid Assembly Modulators Inhibiting HBV in Vitro and in HBV-transgenic Mice. Yin, J., Z. Feng, Z. Li, J. Hu, Y. Hu, X. Cai, H. Zhou, K. Wang, N. Tang, A. Huang, and L. Huang. European Journal of Medicinal Chemistry, 2023. 249: 115141. PMID[36709646].
[PubMed]. HBV_03_2023.

5. Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection. Zhang, W., L. Guo, H. Liu, G. Wu, H. Shi, M. Zhou, Z. Zhang, B. Kou, T. Hu, Z. Zhou, Z. Xu, X. Zhou, Y. Zhou, X. Tian, G. Yang, J.A.T. Young, H. Qiu, G. Ottaviani, J. Xie, A.V. Mayweg, H.C. Shen, and W. Zhu. Journal of Medicinal Chemistry, 2023. 66(6): p. 4253-4270. PMID[36896968].
[PubMed]. HBV_03_2023.

Patent Citations

6. Hepatitis B Virus Antivirus (HBV-antivirus) Compositions and Methods of Use. Chen, M. and C.-Z. Chen. Patent. 2023. WO2022-US43207 2023039243: 207 pp.
[Patent]. HBV_03_2023.

7. Multivalent Interferon Particles Compositions and Methods of Use. Chen, M. and C.-Z. Chen. Patent. 2023. WO2022-US43205 2023039242: 195 pp.
[Patent]. HBV_03_2023.

8. PAPD5 and/or PAPD7 Inhibiting 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid Derivatives and Their Preparation. Harvey, D.M. and S. Ghosh. Patent. 2023. WO2022-US42937 2023039089: 173 pp.
[Patent]. HBV_03_2023.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024